(Q53557508)

15 May 2018

title

Comparison of 7 staging systems for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. (English)

1 reference

15 May 2018

fibrolamellar hepatocellular carcinoma

main subject

patient

0 references

1 reference

2

1 reference

15 May 2018

author name string

Yun Ku Cho

1

1 reference

15 May 2018

Jae Kyun Kim

3

1 reference

15 May 2018

Yong Sik Ahn

4

1 reference

15 May 2018

Mi Young Kim

5

1 reference

15 May 2018

Yoon Ok Park

6

1 reference

15 May 2018

Wan Tae Kim

7

1 reference

15 May 2018

Jong Hoon Byun

8

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 January 2008

1 reference

15 May 2018

published in

Cancer

1 reference

15 May 2018

volume

112

1 reference

15 May 2018

issue

2

1 reference

15 May 2018

page(s)

352-361

1 reference

15 May 2018

Transcatheter oily chemoembolization of hepatocellular carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

Performance status assessment in cancer patients. An inter-observer variability study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma: consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

Simplified staging for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

A new look at the statistical model identification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Evaluating the yield of medical tests

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Trans-catheter arterial chemoembolisation for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End-stage Liver Disease (MELD), in predicting outcome after

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Prospective validation of the Barcelona Clinic Liver Cancer staging system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23185

7 January 2021

Identifiers

DOI

10.1002/CNCR.23185

1 reference

15 May 2018

1 reference

15 May 2018